iShares Biotechnology ETF (NASDAQ:IBB) Shares Bought by PFG Investments LLC

PFG Investments LLC raised its stake in shares of iShares Biotechnology ETF (NASDAQ:IBB) by 118.4% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 4,397 shares of the financial services provider’s stock after purchasing an additional 2,384 shares during the quarter. PFG Investments LLC’s holdings in iShares Biotechnology ETF were worth $597,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also made changes to their positions in IBB. Moneta Group Investment Advisors LLC boosted its position in iShares Biotechnology ETF by 131,598.4% in the fourth quarter. Moneta Group Investment Advisors LLC now owns 4,469,845 shares of the financial services provider’s stock valued at $586,846,000 after buying an additional 4,466,451 shares during the last quarter. JPMorgan Chase & Co. boosted its holdings in shares of iShares Biotechnology ETF by 159.9% in the 1st quarter. JPMorgan Chase & Co. now owns 1,966,359 shares of the financial services provider’s stock valued at $253,975,000 after acquiring an additional 1,209,700 shares during the last quarter. Goldman Sachs Group Inc. increased its stake in shares of iShares Biotechnology ETF by 49.9% in the first quarter. Goldman Sachs Group Inc. now owns 1,568,159 shares of the financial services provider’s stock worth $204,332,000 after acquiring an additional 521,820 shares during the period. Itau Unibanco Holding S.A. purchased a new position in shares of iShares Biotechnology ETF during the third quarter worth $48,242,000. Finally, Two Sigma Advisers LP raised its holdings in shares of iShares Biotechnology ETF by 306.6% during the first quarter. Two Sigma Advisers LP now owns 210,599 shares of the financial services provider’s stock worth $27,201,000 after purchasing an additional 158,800 shares during the last quarter. Hedge funds and other institutional investors own 62.45% of the company’s stock.

iShares Biotechnology ETF Stock Up 1.4 %

NASDAQ:IBB opened at $137.79 on Thursday. The firm’s fifty day moving average is $136.42 and its two-hundred day moving average is $128.75. iShares Biotechnology ETF has a one year low of $111.83 and a one year high of $141.16.

iShares Biotechnology ETF Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Wednesday, March 27th. Stockholders of record on Friday, March 22nd were issued a $0.126 dividend. The ex-dividend date of this dividend was Thursday, March 21st. This represents a $0.50 annualized dividend and a dividend yield of 0.37%.

About iShares Biotechnology ETF

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.